Contact Information
Detailed Information
CMCSB Main A Office
-
Services:
- Prescribes naltrexone
- Buprenorphine maintenance
- Prescribes buprenorphine
- Relapse prevention with naltrexone
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Male
- Female
- Case management service
- Suicide prevention services
- Integrated primary care services
- Social skills development
- Mental health services
- Private health insurance
- Medicaid
- Federal military insurance (e.g., TRICARE)
- Cash or self-payment
- Medicare
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- Individual counseling
- Group counseling
- Local, county, or community government
- Sign language services for the deaf and hard of hearing
- Telemedicine/telehealth therapy
- Matrix Model
- Cognitive behavioral therapy
- Substance use disorder counseling
- Trauma-related counseling
- Relapse prevention
- Motivational interviewing
- Adults
- Young Adults
- Comprehensive mental health assessment
- Interim services for clients
- Screening for mental disorders
- Comprehensive substance use assessment
- Screening for substance use
- Smoking permitted in designated area
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Outpatient
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Assistance with obtaining social services
- Mentoring/peer support
- Self-help groups
- Naloxone and overdose education
- Outcome follow-up after discharge
- Discharge Planning
- Breathalyzer or blood alcohol testing
- Drug and alcohol oral fluid testing
- Metabolic syndrome monitoring
- Drug or alcohol urine screening
- In-network prescribing entity
- State Substance use treatment agency
- State mental health department
- State department of health
- Vaping permitted in designated area
- This facility administers/prescribes medication for alcohol use disorder
- Naltrexone (extended-release, injectable)
- Medication for mental disorders
- Acamprosate (CampralĀ®)
- Naltrexone (oral)
- Buprenorphine (extended-release, injectable)
- Buprenorphine with naloxone
Type of Opioid Treatment
Type of Care
Gender Accepted
Ancillary Services
Payment/Insurance/Funding Accepted
Education and Counseling Services
Facility Operation (e.g., Private, Public)
Language Services
Treatment Approaches
Age Groups Accepted
Assessment/Pre-treatment
Facility Smoking Policy
Opioid Medications used in Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Recovery Support Services
Transitional Services
Testing
External Source of Medications Used for Alcohol Use Disorder Treatment
License/Certification/Accreditation
Facility Vaping Policy
Type of Alcohol Use Disorder Treatment
Pharmacotherapies
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm